Strong revenue growth and product innovations have Wall Street believing that this growth stock will rally 114% over the next 12 months.
Looking for value? These 3 dividend aristocrats are cheap compared with their industry peers.
/CNW/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that Karen Parkhill will resign as executive vice president and...
/Dexcom%20Inc%20HQ-by%20JHVEPhoto%20via%20Shutterstock.jpg)
Despite DexCom’s underperformance compared to its industry, Wall Street analysts remain optimistic about the stock’s prospects.
/CNW/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, is presenting a comprehensive body of new data at the American Diabetes...
/Edwards%20Lifesciences%20Corp%20Irvine%2C%20Ca%20campus-by%20Steve%20Cukrov%20via%20Shutterstock.jpg)
Edwards Lifesciences has recently underperformed the Healthcare sector, but Wall Street analysts anticipate a modest upside for the stock.
/Stryker%20Corp_%20logo%20on%20phone-by%20Piotr%20Swat%20via%20Shutterstock.jpg)
Stryker has recently underperformed the Dow Jones, but Wall Street analysts anticipate a moderate upside for the stock.
They aren't the flashiest stocks, but they get the job done.
/Medtronic%20Plc%20HQ-by%20JHVEPhoto%20via%20iStock.jpg)
Despite Medtronic consistently underperforming the broader healthcare sector, Wall Street analysts remain cautiously optimistic about the stock’s outlook.
/Boston%20Scientific%20Corp_%20logo%20on%20iPad-%20by%20Kate%20Krav-Rude%20via%20Shutterstock.jpg)
Boston Scientific recently reached an all-time high, outperforming the S&P 500 Index, with Wall Street analysts remaining bullish about the stock’s prospects.